Braun J, Baraliakos X, Deodhar AA, et al. Secukinumab Demonstrates Low Radiographic Progression and Sustained Efficacy through 4 Years in Patients with Active Ankylosing Spondylitis. ACR 2017, abstract 3L.
Europese goedkeuring bimekizumab voor PsA en axSpA
jun 2023 | Arthritis psoriatica, Spondyloartritis